Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis

While hemoglobin A1c (HbA1c) is commonly used to monitor therapy response in type 2 diabetes (T2D), GV is emerging as an essential additional metric for optimizing glycemic control. Our goal was to learn more about the impact of hypoglycemic agents on HbA1c levels and GV in patients with T2D. A syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, SuA, Purja, Sujata, Shin, Hocheol, Kim, Minji, Kim, Eunyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189550/
https://www.ncbi.nlm.nih.gov/pubmed/35686694
http://dx.doi.org/10.1177/14791641221106866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189550/
https://www.ncbi.nlm.nih.gov/pubmed/35686694
http://dx.doi.org/10.1177/14791641221106866

Ejemplares similares